Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Quality assessment of five brands of loperamide hydrochloride marketed in Awka capital territory Nigeria

Breadcrumb

  • Home
  • Quality assessment of five brands of loperamide hydrochloride marketed in Awka capital territory Nigeria

Victoria Nonyelum Olli 1, Elizabeth Lilian Okoye-Oti 1, Ekemezie Elochukwu Emmanuel 1 and Jude Nnaemeka Okoyeh 2, *

1 Department of Pharmacology and Toxicology, Chukwuemeka Odumegwu Ojukwu University Igbariam campus Nigeria.
2 Department of Medical Laboratory Science and Biology, School of Health Sciences, Neumann University, One Neumann Drive, Aston, PA, 19014. USA.

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2026, 25(02), 170-176

Article DOI: 10.30574/wjbphs.2026.25.2.0082

DOI url: https://doi.org/10.30574/wjbphs.2026.25.2.0082

Received on 26 December 2025; revised on 03 February 2026; accepted on 06 February 2026

Loperamide hydrochloride (LH) is widely used for the symptomatic control of diarrhoea but there is concern with regards to the efficacy and safety of the diverse generic brands currently in use. Five brands (A, B, C, D and E) of LH were evaluated using uniformity of weight, disintegration time and dissolution time tests as well as HPLC assay.  The paddle method was used for the dissolution test, while the High-Performance Liquid Chromatography (HPLC) was used to determine the quantity of Loperamide hydrochloride in each capsule. 
Brands A, B, D and E passed the uniformity of weight test according USP specifications, whereas brand C failed. Brands A, B, D, and E disintegrated rapidly within 3–7 minutes, demonstrating efficient breakdown of the capsule shell. Brand C however, had a prolonged disintegration time of up to 32.5 minutes. The USP (United States Pharmacopeia) maximum disintegration time is 30 minutes for capsules. Brands A and D had the fastest and most complete dissolution, reaching nearly 100% at 45 minutes. Although brands B and E released the drug slowly, they still achieved acceptable levels. However, brand C exhibited the lowest drug release, reaching only 54 % after 45 minutes. The HPLC assay revealed brands A, B, D and E had percentage mean peak area that fell between 90-110 %, (USP allowed range) while brand C had 79.28 %. Hence brand C Loperamide also failed this test. 
Conclusion: Brand C Loperamide hydrochloride did not meet most of the USP specifications.

Weight Uniformity; Disintegration; Dissolution; HPLC; USP

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0082.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Victoria Nonyelum Olli, Elizabeth Lilian Okoye-Oti, Ekemezie Elochukwu Emmanuel and Jude Nnaemeka Okoyeh. Quality assessment of five brands of loperamide hydrochloride marketed in Awka capital territory Nigeria. World Journal of Biology Pharmacy and Health Sciences, 2026, 25(02), 170–176. Article DOI: https://doi.org/10.30574/wjbphs.2026.25.2.0082

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution